SBC Medical Group Holdings Incorporated

SBC Industrials Consulting Services

SBC Medical Group Holdings Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $173.6 million, down 15.5% from fiscal 2024.

Revenue
+13.4%
EPS
+400.0%
Free cash flow
+396.1%
Total debt
+420.7%

Quarter to June 2026, against a year earlier

4.92 0.10 −1.99%
Market cap
$516.3M
P/E
10.7×
Fwd P/E
11.3×
Dividend yield
—
F-score
3/9
Altman Z
4.74
Beneish M
−1.96
Dividend safety
n/a

SBC Medical Group Holdings Incorporated (SBC) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, SBC Medical Group Holdings Incorporated (SBC) trades at a EV/Sales of 2.1×. Over the past ten years it has ranged from 0.0× (June 2024) to 5.0× (August 2024); the current reading is higher than 90% of that period. That is above the Consulting Services industry median of 1.6× and above the Industrials sector median of 1.8×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.9× (8.73%)
FY2024 2.0× —
FY2023 0.0× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 1.0× (45.80%)
Mar 2026 1.8× (4.18%)
Dec 2025 1.9× (2.21%)
Sep 2025 1.9× 6.87%
8 more quarters

Against its own ten years

Low 0.0× High 5.0×
Ten-year median 1.1×
Current reading's percentile 90

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on SBC